Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer

Expert Opin Ther Targets. 2018 Jan;22(1):1-3. doi: 10.1080/14728222.2018.1406923. Epub 2017 Nov 20.

Daniel Neureiter¹, Tobias Kiesslich², Markus Ritter^{3

4}, Christian Mayr²

¹ a Institute of Pathology , Paracelsus Medical University/Salzburger Landeskliniken , Salzburg , Austria.
² b Department of Internal Medicine I, Paracelsus Medical University/Salzburger Landeskliniken and Laboratory for Tumour Biology and Experimental Therapies, Institute of Physiology and Pathophysiology , Paracelsus Medical University , Salzburg , Austria.
³ c Laboratory for Tumour Biology and Experimental Therapies & Laboratory for Functional and Molecular Membrane Physiology, Institute for Physiology and Pathophysiology , Paracelsus Medical University , Salzburg , Austria.
⁴ d Department for Radon Therapy Research , Ludwig Boltzmann Cluster for Arthritis and Rehabilitation , Salzburg , Austria.

No abstract available

Keywords: BMI1; Biliary tract cancer; PTC-209; polycomb repressive complex.

Publication types